Loading...
01/11 16:21
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call revealed mixed sentiments. Strong enrollment growth and positive guidance for adjusted EBITDA and free cash flow are countered by a projected net loss in Q3 and concerns about APUS registration declines. Cost-saving measures and a lack of specific details on capacity growth and future profit impacts add uncertainty. Overall, the neutral sentiment reflects balanced positive and negative factors, with no clear catalyst for significant stock movement.
Total Revenue $163.2 million, an increase of $10.1 million or 7% from the prior year period. Excluding Graduate School USA, revenue would have been 5% higher, or aggregate growth of 12%.
Net Income $5.6 million, almost 7x higher than $700,000 in the prior year. EPS increased to $0.30 per diluted share from $0.04 in the prior year.
Adjusted EBITDA $20.7 million, a 60% increase from $12.9 million in the prior year, with a margin expansion of 424 basis points.
APUS Revenue $83.1 million, an 8% increase year-over-year, driven by an 8% increase in net course registrations.
Rasmussen Revenue $60.8 million, a 16% increase year-over-year, fueled by a 12% increase in on-ground enrollment and an 11% increase in online enrollment.
Hondros College of Nursing Revenue $18.4 million, a 19% increase year-over-year, driven by an 18% increase in total enrollment.
Cash Flow from Operations $73.5 million for the 9 months ended September 30, 2025, a 56% increase year-over-year.
Free Cash Flow $45.2 million for the 9-month period, nearly doubling from the prior year.
Total Cash, Cash Equivalents, and Restricted Cash $193.1 million as of September 30, 2025, a 22% increase year-over-year.
Net Cash Position $96.7 million at quarter end, after subtracting $96.4 million secured note.
Enrollment Growth: Rasmussen enrollments increased 10% year-over-year, marking the fifth consecutive quarter of growth. Hondros College of Nursing enrollments grew 18% year-over-year.
Revenue Growth: APEI's total revenue for Q3 2025 was $163.2 million, a 7% increase from the prior year. APUS revenue increased 8%, Rasmussen revenue grew 16%, and Hondros revenue rose 19%.
Market Positioning: APEI sold Graduate School USA, focusing on its core degree-granting institutions in military, veterans, nursing, and healthcare sectors.
Government Shutdown Impact: Military enrollments at APUS were muted in October and November due to the government shutdown, but tuition assistance funds are expected to resume.
Operational Simplification: APEI completed the sale of Graduate School USA, reducing liabilities by $28 million and saving $4 million annually in lease payments. The company also redeemed preferred equity, saving $6 million annually in dividends.
Financial Flexibility: APEI's unrestricted cash and equivalents totaled $193.1 million as of September 30, 2025, with improved cash flow of $10 million annually.
Strategic Focus: APEI is prioritizing the combination of its degree-granting institutions and submitted a new application to the Department of Education for approval, expected to take effect in Q3 2026.
Government Shutdown Impact: The government shutdown has negatively impacted military enrollments at APUS for October and November. This has led to muted enrollments and delays in tuition assistance approvals, which are critical for military students. The company has implemented cost-saving measures to mitigate these adverse impacts.
Regulatory and Process Challenges: APEI faced delays in the planned combination of its institutions due to a change in the process required by the Department of Education. This has pushed the timeline for the combination plan to the third quarter of 2026, potentially impacting operational and strategic objectives.
Financial Constraints from Divestitures: The sale of Graduate School USA, while aligning with strategic priorities, resulted in a $3.9 million loss and reduced revenue by $18 million for the year. This divestiture also eliminated a $28 million lease liability but may constrain short-term financial flexibility.
Advertising Cost Increases: APEI experienced a $2.5 million increase in advertising costs aimed at driving student enrollment growth. While this is an investment, it adds to operational costs and could pressure margins if enrollment growth does not meet expectations.
Economic and Market Uncertainty: The company is exposed to broader economic uncertainties, including potential impacts on student enrollments and financial aid availability, particularly in the context of government funding and appropriations.
Revenue Guidance: For the full year 2025, consolidated revenue is expected to be between $640 million and $644 million, revised due to the government shutdown. Fourth quarter 2025 revenue is projected to be between $150 million and $153.5 million.
Net Income Guidance: Net income available to common shareholders for the full year 2025 is expected to be between $17.2 million and $19.6 million. Fourth quarter net income is projected to be between $5.9 million and $8.3 million, or $0.32 to $0.45 per diluted share.
Adjusted EBITDA Guidance: Full year 2025 adjusted EBITDA is expected to be between $75 million and $79 million. Fourth quarter adjusted EBITDA is projected to be between $18.5 million and $22 million.
Enrollment Projections: Fourth quarter 2025 APUS net course registrations are expected to decrease by 23% to 33% year-over-year due to the government shutdown. Rasmussen's fourth quarter enrollment is projected to increase by 9% year-over-year to approximately 15,900 students. Hondros College of Nursing's fourth quarter enrollment is expected to grow by 9% year-over-year to approximately 4,000 students.
Free Cash Flow Expectations: Full year 2025 free cash flow, defined as adjusted EBITDA less CapEx, is expected to be between $58 million and $64 million.
Capital Expenditures: Full year 2025 CapEx is expected to be between $15 million and $17 million.
Operational Changes and Simplification: The company has improved its financial flexibility and capital structure by redeeming preferred equity, selling corporate buildings, and simplifying its business structure. These actions are expected to save approximately $10 million annually on a pretax basis.
Future Growth Strategy: APEI plans to focus on growth in its core degree-granting businesses, including military, veterans, nursing, and healthcare communities. The company is optimistic about its long-term growth potential and plans to provide more details during its November 20, 2025, Investor Day.
Cash dividend payments: The company has eliminated cash dividend payments, saving approximately $6 million annually.
Preferred equity redemption: The company redeemed its preferred equity at the end of the second quarter, saving approximately $6 million annually from the elimination of cash dividend payments.
The earnings call revealed mixed sentiments. Strong enrollment growth and positive guidance for adjusted EBITDA and free cash flow are countered by a projected net loss in Q3 and concerns about APUS registration declines. Cost-saving measures and a lack of specific details on capacity growth and future profit impacts add uncertainty. Overall, the neutral sentiment reflects balanced positive and negative factors, with no clear catalyst for significant stock movement.
The earnings call shows strong financial metrics, such as increased EBITDA, cash flow, and unrestricted cash. Despite some negative aspects like reduced Graduate School revenue and unclear military funding distribution, the overall sentiment is positive. The consolidation plan, breakeven status of Rasmussen and Hondros, and increased guidance for EBITDA and net income further support this view. The Q&A reveals potential growth through consolidation and military enrollments, although some management responses lacked clarity. Overall, the positive aspects outweigh the negatives, suggesting a likely stock price increase.
The earnings call reveals strong financial performance with increased revenue, EBITDA, and cash flow, alongside strategic initiatives like the consolidation of institutions and redemption of preferred shares. Despite some operational risks and unclear guidance on certain aspects, the overall sentiment is positive due to improved profitability and strategic cost reductions. The anticipated savings from preferred share redemption and asset sales further bolster this outlook, suggesting a likely positive stock reaction.
The earnings call highlights strong financial performance with increased revenue, improved profitability, and expanded margins. Despite some uncertainties in graduate school guidance and consolidation synergies, the overall sentiment is bolstered by positive enrollment trends, especially in nursing, and strategic cost management. The Q&A section reveals confidence in handling potential challenges, such as the portal outage and economic cyclicality. With optimistic guidance and strategic initiatives, the stock is likely to experience a positive movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
